BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 20, 2010
 |  BC Week In Review  |  Company News  |  Deals

Cypress Bioscience, Ramius LLC deal

Cypress shareholder Ramius began an unsolicited tender offer to acquire the 90.1% of Cypress it does not already own for $4.25 per share in cash. The offer values Cypress at about $164 million based on 38.6 million shares outstanding at Aug. 5. It is a 70% premium to...

Read the full 219 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >